Reuters logo
8 months ago
BRIEF-NW Bio announces decision to voluntarily withdraw from Nasdaq listing and begin trading on OTC Market
December 8, 2016 / 1:12 AM / 8 months ago

BRIEF-NW Bio announces decision to voluntarily withdraw from Nasdaq listing and begin trading on OTC Market

Dec 7 (Reuters) - Northwest Biotherapeutics Inc

* Says desires to proceed with multiple Phase 2 trials in addition to completing its current Phase 3 trial

* NW Bio announces decision to voluntarily withdraw from Nasdaq listing and begin trading on OTC Market

* Says Nasdaq is expected to be suspended on or about December 19, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below